Retrospective reports from literature have shown a lower rate of infections for transperineal versus transrectal approach for prostate biopsies in the setting of prostate cancer suspicion. The aim of this study would be to compare in a prospective randomized trial the rate of infection with transperineal versus transrectal approach.
Retrospective reports from literature have shown a lower rate of infections for the transperineal versus transrectal approach for prostate biopsies in the setting of prostate cancer suspicion. Post-biopsy infection is becoming a more and more challenging situation due to the increase of incidence and development of antibiotic resistant germs. The aim of this study would be to compare in a prospective randomized trial the rate of infection with transperineal vs transrectal approach. Patient presenting an indication of prostate biopsy (PSA elevation, suspicious lesion at digital rectal, suspicious lesion on MRI) would be randomized 1:1 among transrectal vs transperineal biopsies. Post-biopsy infection would be monitored by systemic urine analysis at one, two and four weeks after procedure and in case of clinical symptoms.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
340
Puncture of 12 to 30 percutaneous prostate core biopsies through the perineum with a transrectal ultrasound probe guidance. The procedure would be performed with the Artemis (Eigen) device allowing topographic recording of the puncture and MRI / ultrasound image fusion in order to target the MRI suspected lesion.
Patient would undergo 12 to 30 transrectal prostate core biopsies through the rectum with a transrectal ultrasound probe guidance. The procedure would be performed with the Artemis (Eigen) device allowing topographic recording of the puncture and MRI / ultrasound image fusion in order to target the MRI suspected lesion.
Institut Mutualiste Montsouris
Paris, France
Rate of post-biopsy infection from Baseline to four weeks after prostate biopsy
Urinary infection will be assessed based on urinanalysis : 10\^5 germs and 10\^4 leucocytes minimum)
Time frame: Four weeks post-biopsy
Presence of antibiotic resistant germ
Antibiotic resistant germ will be assessed on urinanalysis
Time frame: One week, two weeks and four weeks post-biopsy
Presence of complication post-biopsy : hematuria, urinary retention, rectoragy, any other complication
Presence of complication will be assessed during phone interview with the patient
Time frame: One week, two weeks and four weeks post-biopsy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.